ResearcherLanzhou University Second HospitalNo recent work listed

Xuechen Ren

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-5924-8792; OpenAlex author ID A5002107285. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 2 papers

Papers 2

Single-cell RNA-seq reveals invasive trajectory and determines cancer stem cell-related prognostic genes in pancreatic cancer. Co-author DOI 10.1080/21655979.2021.1962484 ↗
The Crosstalk Between Malignant Cells and Tumor-Promoting Immune Cells Relevant to Immunotherapy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fcell.2021.821232 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yu Lu · 1 shared paper, 2021 · strength 0.16
- Paper Single-cell RNA-seq reveals invasive trajectory and determines cancer stem cell-related prognostic genes in pancreatic … DOI 10.1080/21655979.2021.1962484 ↗
Chen Wang · 1 shared paper, 2021 · strength 0.16
- Paper Single-cell RNA-seq reveals invasive trajectory and determines cancer stem cell-related prognostic genes in pancreatic … DOI 10.1080/21655979.2021.1962484 ↗
Xuefei Liu · 1 shared paper, 2021 · strength 0.15
- Paper The Crosstalk Between Malignant Cells and Tumor-Promoting Immune Cells Relevant to Immunotherapy in Pancreatic Ductal A… DOI 10.3389/fcell.2021.821232 ↗
Zhixiang Zuo · 1 shared paper, 2021 · strength 0.15
- Paper The Crosstalk Between Malignant Cells and Tumor-Promoting Immune Cells Relevant to Immunotherapy in Pancreatic Ductal A… DOI 10.3389/fcell.2021.821232 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.